Comprehensive geriatric assessment and its clinical impact in oncology

doi:10.3760/cma.j.issn.1673-422X.2014.05.004

Abstract

Abstract: With the aging of the population,management of cancer in the elderly aged people represents a priority for health care. However, fewer evidencebased data are available to promote the treatment of these patients. Comprehensive geriatric assessment (CGA) is developed recently as a multidisciplinary indepth evaluation to assess life expectancy and risk of morbidity from cancer in elderly patients, which is helpful for physicians to develop a coordinated plan for cancer treatment and to provide appropriate interventions to decrease the risk of morbidity and mortality.

Key words: Neoplasms, Aged, Health status indicators, Evaluation, Complications

Liu Xiaolin, Liang Jing. Comprehensive geriatric assessment and its clinical impact in oncology[J]. Journal of International Oncology, 2014, 41(5): 332-334.

References

［1］ Smith BD, Smith GL, Hurria A, et al. Future of cancer incidence in the United States: burdens upon an aging, changing nation［J］. J Clin Oncol, 2009, 27(17):2758-2765. ［2］ Hurria A, Cirrincione CT, Muss HB, et al. Implementing a geriatric assessment in cooperative group clinical cancer trials: CALGB 360401［J］. J Clin Oncol, 2011, 29(10):1290-1296. ［3］ McCorkle R, Strumpf NE, Nuamah IF, et al. A specialized home care intervention improves survival among older postsurgical cancer patients［J］. J Am Geriatr Soc, 2000, 48(12):1707-1713. ［4］ Tucci A, Ferrari S, Bottelli C, et al. A comprehensive geriatric assessment is more effective than clinical judgment to identify elderly diffuse large cell lymphoma patients who benefit from aggressive therapy［J］. Cancer, 2009, 115(19):4547-4553. ［5］ Chaibi P, Magné N, Breton S, et al. Influence of geriatric consultation with comprehensive geriatric assessment on final therapeutic decision in elderly cancer patients［J］. Crit Rev Oncol Hematol, 2011, 79(3):302-307. ［6］ Caillet P, CanouiPoitrine F, Vouriot J, et al. Comprehensive geriatric assessment in the decisionmaking process in elderly patients with cancer: ELCAPA study［J］. J Clin Oncol, 2011, 29(27):3636-3642. ［7］ Barthélémy P, Heitz D, Mathelin C, et al. Adjuvant chemotherapy in elderly patients with early breast cancer. Impact of age and comprehensive geriatric assessment on tumor board proposals［J］. Crit Rev Oncol Hematol, 2010, 79(2):196-204. ［8］ Cudennec T, Gendry T, Labrune S, et al. Use of a simplified geriatric evaluation in thoracic oncology［J］. Lung Cancer, 2010, 67(2):232-236. ［9］ Pilotto A, Ferrucci L, Franceschi M, et al. Development and validation of a multidimensional prognostic index for oneyear mortality from comprehensive geriatric assessment in hospitalized older patients［J］. Rejuvenation Res, 2008, 11(1):151-161. ［10］ Tulner LR, van Campen JP, Frankfort SV, et al. Changes in undertreatment after comprehensive geriatric assessment: an observational study［J］. Drugs Aging, 2010, 27(10):831-843. ［11］ Kim YJ, Kim JH, Park MS, et al. Comprehensive geriatric assessment in Korean elderly cancer patients receiving chemotherapy［J］. J Cancer Res Clin Oncol, 2011, 137(5):839-847. ［12］ Extermann M, Meyer J, McGinnis M, et al. A comprehensive geriatric intervention detects multiple problems in older breast cancer patients［J］. Crit Rev Oncol Hematol, 2004, 49(1):69-75. ［13］ Winkelmann N, Petersen I, Kiehntopf M, et al. Results of comprehensive geriatric assessment effect survival in patients with malignant lymphoma［J］. J Cancer Res Clin Oncol, 2011, 137(4):733-738. ［14］ Kristjansson SR, Nesbakken A, Jordhy MS, et al. Comprehensive geriatric assessment can predict complications in elderly patients after elective surgery for colorectal cancer: a prospective observational cohort study［J］. Crit Rev Oncol Hematol, 2010, 76(3):208-217. ［15］ Basso U, Falci C, Brunello A, et al. Prognostic value of multidimensional geriatric assessment (MGA) on survival of a prospective cohort of 880 elderly cancer patients (ECP)［J］. J Clin Oncol, 2011, 29 Suppl:9065. ［16］ Goodwin JS, Satish S, Anderson ET, et al. Effect of nurse case management on the treatment of older women with breast cancer［J］. J Am Geriatr Soc, 2003, 51(9):1252-1259.

[1]	Liu Na, Kou Jieli, Yang Feng, Liu Taotao, Li Danping, Han Junrui, Yang Lizhou. Clinical value of serum miR-106b-5p and miR-760 combined with low-dose spiral CT in the diagnosis of early lung cancer [J]. Journal of International Oncology, 2024, 51(6): 321-325.
[2]	Yang Mi, Bie Jun, Zhang Jiayong, Deng Jiaxiu, Tang Zuge, Lu Jun. Analysis of the efficacy and prognosis of neoadjuvant therapy for locally advanced resectable esophageal cancer [J]. Journal of International Oncology, 2024, 51(6): 332-337.
[3]	Yuan Jian, Huang Yanhua. Diagnostic value of Hp-IgG antibody combined with serum DKK1 and sB7-H3 in early gastric cancer [J]. Journal of International Oncology, 2024, 51(6): 338-343.
[4]	Chen Hongjian, Zhang Suqing. Study on the relationship between serum miR-24-3p， H2AFX and clinical pathological features and postoperative recurrence in liver cancer patients [J]. Journal of International Oncology, 2024, 51(6): 344-349.
[5]	Guo Zehao, Zhang Junwang. Role of PFDN and its subunits in tumorigenesis and tumor development [J]. Journal of International Oncology, 2024, 51(6): 350-353.
[6]	Zhang Baihong, Yue Hongyun. Advances in anti-tumor drugs with new mechanisms of action [J]. Journal of International Oncology, 2024, 51(6): 354-358.
[7]	Xu Fenglin, Wu Gang. Research progress of EBV in tumor immune microenvironment and immunotherapy of nasopharyngeal carcinoma [J]. Journal of International Oncology, 2024, 51(6): 359-363.
[8]	Wang Ying, Liu Nan, Guo Bing. Advances of antibody-drug conjugate in the therapy of metastatic breast cancer [J]. Journal of International Oncology, 2024, 51(6): 364-369.
[9]	Zhang Rui, Chu Yanliu. Research progress of colorectal cancer risk assessment models based on FIT and gut microbiota [J]. Journal of International Oncology, 2024, 51(6): 370-375.
[10]	Gao Fan, Wang Ping, Du Chao, Chu Yanliu. Research progress on intestinal flora and non-surgical treatment of the colorectal cancer [J]. Journal of International Oncology, 2024, 51(6): 376-381.
[11]	Liu Jing, Liu Qin, Huang Mei. Prognostic model construction of lung infection in patients with chemoradiotherapy for esophageal cancer based on SMOTE algorithm [J]. Journal of International Oncology, 2024, 51(5): 267-273.
[12]	Yang Lin, Lu Ning, Wen Hua, Zhang Mingxin, Zhu Lin. Study on the clinical relationship between inflammatory burden index and gastric cancer [J]. Journal of International Oncology, 2024, 51(5): 274-279.
[13]	Wang Junyi, Hong Kaibin, Ji Rongjia, Chen Dachao. Effect of cancer nodules on liver metastases after radical resection of colorectal cancer [J]. Journal of International Oncology, 2024, 51(5): 280-285.
[14]	Zhang Ningning, Yang Zhe, Tan Limei, Li Zhenning, Wang Di, Wei Yongzhi. Diagnostic value of cervical cell DNA ploidy analysis combined with B7-H4 and PKCδ for cervical cancer [J]. Journal of International Oncology, 2024, 51(5): 286-291.
[15]	Fu Yi, Ma Chenying, Zhang Lu, Zhou Juying. Research progress of habitat analysis in radiomics of malignant tumors [J]. Journal of International Oncology, 2024, 51(5): 292-297.